Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer

Clinical Biochemistry

Volumn 41, Issue 10-11, 2008, Pages 824-830

  Yu, Man ^a,b   Wan, Yanfang ^c   Zou, Qinghua ^d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d Pipeline Sci Res Inst of China   (China)

Author keywords

BP1; Homeobox; NSCLC; Prognosis; Real time RT PCR

Indexed keywords

BETA PROTEIN 1; MESSENGER RNA; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; P53 GENE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; SMOKING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 44949257965     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.03.011     Document Type: Article

References (38)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 57 (2007) 43-66
2. Parkin D.M., Whelan S.L., Ferlay J., and Storm H. Cancer incidence in five continents (2005), IARC, Lyon Vols. I to VIII
3. Travis M.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart (2004), IARC, Lyon
4. Cillo C., Cantile M., Faiella A., and Boncinelli E. Homeobox genes in normal and malignant cells. J Cell Physiol 188 (2001) 161-169
5. Samuel S., and Naora H. Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur J Cancer 41 (2005) 2428-2437
6. Chen Y., Petersen S., Pacyna-Gengelbach M., Pietas A., and Petersen I. Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer. Oncology 64 (2003) 450-458
7. Chen Y., Pacyna-Gengelbach M., Deutschmann N., Niesporek S., and Petersen I. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. Int J Cancer 121 (2007) 1021-1027
8. Ohta H., Hamada J., Tada M., et al. HOXD3-overexpression increases integrin alpha v beta 3 expression and deprives E-cadherin while it enhances cell motility in A549 cells. Clin Exp Metastasis 23 (2006) 381-390
9. Hamada J.i., Omatsu T., Okada F., et al. Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 93 (2001) 516-525
10. Fu S., Stevenson H., Strovel J.W., et al. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene 278 (2001) 131-139
11. Chase M.B., Fu S., Haga S.B., et al. BP1, a homeodomain-containing isoform of DLX4, represses the β-globin gene. Mol Cell Biol 22 (2002) 2505-2514
12. Mpolo M.S., Beaudoin M., Berg P.E., Beauchemin H., D'Agati V., and Trudel M. BP1 is a negative modulator of definitive erythropoiesis. Nucleic Acids Res 34 (2006) 5232-5237
13. Haga S.B., Fu S., Karp J.E., et al. BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia 14 (2000) 1867-1875
14. Fu S.W., Schwartz A., Stevenson H., et al. Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Breast Cancer Res 5 (2003) R82
15. Man Y.G., Fu S.W., Schwartz A., Pinzone J.J., Simmens S.J., and Berg P.E. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat 90 (2005) 241-247
16. Xian Y.S., Dang C.X., Yan C.X., Li H.P., Fu S.W., and Wang Z.R. Clinicopathological significance of homeobox BP1 mRNA expression in lung cancer tissue. Nan Fang Yi Ke Da Xue Xue Bao 26 (2006) 1173-1175
17. Stevenson H.S., Fu S.W., Pinzone J.J., Rheey J., Simmens S.J., and Berg P.E. BP1 transcriptionally activates bcl-2 and inhibits TNF alpha-induced cell death in MCF7 breast cancer cells. Breast Cancer Res 9 (2007) R60
18. Awwad R.T., Do K., Stevenson H., et al. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells. Ann Hematol 87 (2008) 195-203
19. Yu M., Yang Y., Shi Y., et al. Expression level of beta protein 1 mRNA in Chinese breast cancer patients: a potential molecular marker for poor prognosis. Cancer Sci 99 (2008) 173-178
20. Matsuzoe D., Hideshima T., Ohshima K., Kawahara K., Shirakusa T., and Kimura A. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer 79 (1999) 1549-1552
21. Gessner C., Kuhn H., Toepfer K., Hammerschmidt S., Schauer J., and Wirtz H. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 43 (2004) 215-222
22. Mitsudomi T., Hamajima N., Ogawa M., and Takahashi T. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 6 (2000) 4055-4063
23. Mori S., Ito G., Usami N., et al. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Cancer 10 (2004) 1673-1682
24. Laudanski J., Niklinska W., Burzykowski T., Chyczewski L., and Niklinski J. Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer. Eur Respir J 17 (2001) 660-666
25. Fontanini G., Boldrini L., Vignati S., et al. Bcl-2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. Eur J Cancer 34 (1998) 718-723
26. Roth-Kleiner M., and Post M. Genetic control of lung development. Biol Neonate 84 (2003) 83-88
27. Shi W., Bellusci S., and Warburton D. Lung development and adult lung diseases. Chest 132 (2007) 651-656
28. Kuwano K., Yoshimi M., Maeyama T., Hamada N., Yamada M., and Nakanishi Y. Apoptosis signaling pathways in lung diseases. Med Chem 1 (2005) 49-56
29. Daniel V.C., Peacock C.D., and Watkins D.N. Developmental signaling pathways in lung cancer. Respirology 11 (2006) 234-240
30. Levin W.J., Casey G., Ramos J.C., Arboleda M.J., Reissmann P.T., and Slamon D.J. Tumor suppressor and immediate early transcription factor genes in non-small cell lung cancer. Chest 10 (1994) 372S-376S
31. Salgia R., and Skarin A.T. Molecular abnormalities in lung cancer. J Clin Oncol 16 (1998) 1207-1217
32. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence?. Nat Rev Cancer 2 (2002) 777-785
33. Zerucha T., and Ekker M. Distal-less-related homeobox genes of vertebrates: evolution, function, and regulation. Biochem Cell Biol 78 (2000) 593-601
34. Yu M., Yang Y., Niu R., et al. Clinicopathological significance of homeobox gene BP1 mRNA expression in human breast cancer. Chin J Cancer 23 (2004) 855-859
35. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., et al. The c-myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66 (2006) 5330-5337
36. Sirzén F., Zhivotovsky B., Nilsson A., Bergh J., and Lewensohn R. Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bcl-2/Bax. Lung Cancer 22 (1998) 1-13
37. Lu C., Soria J.C., Tang X., et al. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers. J Clin Oncol 22 (2004) 4575-4583
38. Song Y.C., Fu S.D., Wen X.P., Ma Z.H., and Dang C.X. Expression and significance of BP1 gene and cyclin D1 gene in breast cancer. Chin J Cancer 26 (2007) 709-714